A novel oral indoline-sulfonamide agent; J30; exhibits potent activity against human cancer cells in vitro and in vivo through the disruption of microtubule.

Type
article
Resource
J. Pharmacol. Exp. Ther.(323):398-405.
Date Issued
2007
Author(s)
Liou JP; Hsu KS; Kuo CC; Chang CY; Chang JY;
Subjects
藥學系
期刊論文
URI

Copyright Notice

● The digital content on this platform is part of the Taipei Medical University Institutional Repository, featuring various academic works and outputs from the institution. It offers free access to academic research and public education for non-commercial use.

● Please use the content appropriately and within legal boundaries to respect copyright owners' rights. For commercial use, please obtain prior authorization from the copyright owner. Users must not use TMUIR for any illegal purposes.

● By utilising the platform, users are deemed to have fully accepted and understood all the regulations set out in this statement, relevant laws of the Republic of China, all international internet regulations, and usage conventions.

● TMUIR is committed to protecting the interests of copyright owners. If you believe that any material on this website infringes copyright, please contact our staff at libirtmu@gmail.com, and we will remove the work from the repository.

Built with DSpace-CRIS software - Extension maintained and optimized by 4Science